Global Health Economics is a consulting firm that advises on drug listing recommendations and pricing strategy. They operate from Summit and Sydney and offer econometricians, outcome researchers, statisticians and health economic medical writers with knowledge and experience in Canadian, Australian, European, Asian and American markets.